Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
- Status
- RECRUITING
- Phase
- N/A
Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients
- Status
- COMPLETED
- Phase
- N/A
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Almonertinib Plus Metronomic Oral Vinorelbine
- Status
- UNKNOWN
- Phase
- N/A
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Milciclib in Combination With Gemcitabine in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- Status
- RECRUITING
- Phase
- N/A
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases
- Status
- UNKNOWN
- Phase
- NA